An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at Washington University School of Medicine in St. Louis.
Experimental drug shows promise in reducing risk of Alzheimer’s-related dementia
- Post author:admin
- Post published:March 19, 2025
- Post category:uncategorized
- Post comments:0 Comments